AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32950505 — intervention group
Group type: EXPERIMENTAL
Intervention: Instagram use during presentation of new information
Number of subjects: 45
Study 32950505 — intervention group
Group type: EXPERIMENTAL
Intervention: Instagram use after presentation of new information
Number of subjects: 45
Study 32950505 — intervention group
Group type: COMPARATOR
Intervention: No Instagram use (control group)
Number of subjects: 45
Study 34438089 — intervention group
Group type: EXPERIMENTAL
Intervention: UAVS
Number of subjects: 40
Study 34438089 — intervention group
Group type: COMPARATOR
Intervention: EVLA
Number of subjects: 40
Study 32533985 — intervention group
Group type: EXPERIMENTAL
Intervention: Frozen embryo transfer 2–5 h after thaw (Group D2)
Number of subjects: 388
Study 32533985 — intervention group
Group type: EXPERIMENTAL
Intervention: Frozen embryo transfer 18–24 h after thaw (Group D2/D3)
Number of subjects: 388
Study 33933666 — intervention group
Group type: EXPERIMENTAL
Intervention: No Practice Effects (NPE) cognitive battery
Number of subjects: 320
Study 33933666 — intervention group
Group type: EXPERIMENTAL
Intervention: Miami Computerized Functional Assessment Scale (CFAS)
Number of subjects: 320
Study 33933666 — intervention group
Group type: COMPARATOR
Intervention: Preclinical Alzheimer Cognitive Composite (PACC)
Number of subjects: 320
Study 33933666 — intervention group
Group type: COMPARATOR
Intervention: Alzheimer's Disease Assessment Scale‐Cognitive Subscale (ADAS‐Cog)
Number of subjects: 320
Study 33933666 — intervention group
Group type: COMPARATOR
Intervention: Functional Activities Questionnaire (FAQ)
Number of subjects: 320
Study 35907840 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance training intervention
Number of subjects: 15
Study 33938765 — intervention group
Group type: EXPERIMENTAL
Intervention: Utility-value reflection (n = 39)
Number of subjects: 73
Study 33938765 — intervention group
Group type: COMPARATOR
Intervention: Control picture-summarization task (n = 34)
Number of subjects: 73
Study 34587534 — intervention group
Group type: EXPERIMENTAL
Intervention: Exergames with physiotherapy support
Number of subjects: 71
Study 34587534 — intervention group
Group type: COMPARATOR
Intervention: Standard postoperative physiotherapy
Number of subjects: 71
Study 33144592 — intervention group
Group type: EXPERIMENTAL
Intervention: Normal P conditions (7551 ppm)
Number of subjects: 50
Study 33144592 — intervention group
Group type: EXPERIMENTAL
Intervention: Reduced P conditions (4459 ppm)
Number of subjects: 50
Study 33144592 — intervention group
Group type: COMPARATOR
Intervention: Limited P conditions
Number of subjects: 50
Study 33144592 — intervention group
Group type: COMPARATOR
Intervention: Normal P conditions
Number of subjects: 50
Study 33442915 — intervention group
Group type: EXPERIMENTAL
Intervention: VR intervention (8 h within 2 weeks) plus 8-h occupational therapy (OT)
Number of subjects: 23
Study 33442915 — intervention group
Group type: COMPARATOR
Intervention: Control group (time-matched OT alone)
Number of subjects: 23
Study 33080380 — intervention group
Group type: EXPERIMENTAL
Intervention: Rubber Band Ligation (RBL)
Number of subjects: 558
Study 33080380 — intervention group
Group type: EXPERIMENTAL
Intervention: Sutured Mucopexy
Number of subjects: 558
Study 33080380 — intervention group
Group type: EXPERIMENTAL
Intervention: Haemorrhoidectomy
Number of subjects: 558
Study 33080380 — intervention group
Group type: COMPARATOR
Intervention: Cost-effectiveness analysis
Number of subjects: 558
Study 33080380 — intervention group
Group type: COMPARATOR
Intervention: Secondary outcomes
Number of subjects: 558
Study 35511704 — intervention group
Group type: EXPERIMENTAL
Intervention: Glepaglutide 1 mg
Number of subjects: 18
Study 35511704 — intervention group
Group type: EXPERIMENTAL
Intervention: Glepaglutide 10 mg
Number of subjects: 18
Study 35511704 — intervention group
Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 18
Study 34137527 — intervention group
Group type: EXPERIMENTAL
Intervention: Articaine 4% IANB with Buccal Infiltration
Number of subjects: 160
Study 34137527 — intervention group
Group type: COMPARATOR
Intervention: Lidocaine 2% IANB with Buccal Infiltration
Number of subjects: 160
Study 32912952 — intervention group
Group type: EXPERIMENTAL
Intervention: Personalised incentives (four schemes: Standard, Descending, Ascending, Deposit)
Number of subjects: 220
Study 32912952 — intervention group
Group type: COMPARATOR
Intervention: Control group (no incentives)
Number of subjects: 220
Study 34978076 — intervention group
Group type: EXPERIMENTAL
Intervention: 15 mg INCB054707 QD (Study 1)
Number of subjects: 45
Study 34978076 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 mg INCB054707 QD (Study 2)
Number of subjects: 45
Study 34978076 — intervention group
Group type: EXPERIMENTAL
Intervention: 60 mg INCB054707 QD (Study 2)
Number of subjects: 45
Study 34978076 — intervention group
Group type: EXPERIMENTAL
Intervention: 90 mg INCB054707 QD (Study 2)
Number of subjects: 45
Study 34978076 — intervention group
Group type: COMPARATOR
Intervention: Placebo (Study 2)
Number of subjects: 45
Study 34608858 — intervention group
Group type: EXPERIMENTAL
Intervention: Newer non-wearable device (Beddit 3.5)
Number of subjects: 35
Study 34608858 — intervention group
Group type: EXPERIMENTAL
Intervention: Early version of the non-wearable device (Beddit 3.0)
Number of subjects: 35
Study 32728734 — intervention group
Group type: EXPERIMENTAL
Intervention: HERO intervention (8-session cognitive-behavioral therapy)
Number of subjects: 34
Study 32728734 — intervention group
Group type: COMPARATOR
Intervention: Usual Care (UC) group
Number of subjects: 34
Study 34325950 — intervention group
Group type: EXPERIMENTAL
Intervention: Circulating homocysteine levels
Number of subjects: 27
Study 34325950 — intervention group
Group type: EXPERIMENTAL
Intervention: Circulating vitamin B6 levels
Number of subjects: 27
Study 34325950 — intervention group
Group type: EXPERIMENTAL
Intervention: Circulating vitamin B12 levels
Number of subjects: 27
Study 34325950 — intervention group
Group type: EXPERIMENTAL
Intervention: Circulating folate acid levels
Number of subjects: 27
Study 35436524 — intervention group
Group type: EXPERIMENTAL
Intervention: Trial participants (EORTC boost-no boost trial)
Number of subjects: 20880
Study 35436524 — intervention group
Group type: COMPARATOR
Intervention: Non-trial participants
Number of subjects: 20880
Study 33930498 — intervention group
Group type: EXPERIMENTAL
Intervention: Vegetarians
Number of subjects: 412
Study 33930498 — intervention group
Group type: EXPERIMENTAL
Intervention: Vegans
Number of subjects: 412
Study 33930498 — intervention group
Group type: EXPERIMENTAL
Intervention: Flexitarians
Number of subjects: 412
Study 33930498 — intervention group
Group type: COMPARATOR
Intervention: Omnivores
Number of subjects: 412
Study 32645227 — intervention group
Group type: EXPERIMENTAL
Intervention: Blood flow restriction‐empowered low‐intensity interval walking exercise (BFR‐W)
Number of subjects: 24
Study 32645227 — intervention group
Group type: COMPARATOR
Intervention: Conventional intensive overground walking (CON‐W)
Number of subjects: 24
Study 35526858 — intervention group
Group type: EXPERIMENTAL
Intervention: L-carnitine (2 g/day)
Number of subjects: 150
Study 35526858 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 150
Study 34226018 — intervention group
Group type: EXPERIMENTAL
Intervention: Sentinel lymph node (SLN) mapping
Number of subjects: 245
Study 34226018 — intervention group
Group type: EXPERIMENTAL
Intervention: FDG‐PET/CT imaging
Number of subjects: 245
Study 34226018 — intervention group
Group type: EXPERIMENTAL
Intervention: Completion pelvic lymphadenectomy
Number of subjects: 245
Study 33198657 — intervention group
Group type: EXPERIMENTAL
Intervention: HPV-16/18 AS04-adjuvanted vaccine
Number of subjects: 168
Study 34501459 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrochemotherapy (ECT) followed by conventional systemic treatment (FOLFOXIRI)
Number of subjects: 90
Study 34501459 — intervention group
Group type: COMPARATOR
Intervention: Conventional chemotherapy (FOLFOXIRI)
Number of subjects: 90
Study 32063448 — intervention group
Group type: EXPERIMENTAL
Intervention: rTMS (5‐Hz; 500 pulses/session; figure‐8 coil) on primary motor cortex
Number of subjects: 11
Study 615704919 — intervention group
Group type: EXPERIMENTAL
Intervention: C1INH (20U/kg/dose) intra-operatively, then 2x weekly for 7 doses
Number of subjects: 20
Study 615704919 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 615704919 — intervention group
Group type: EXPERIMENTAL
Intervention: C1INH
Number of subjects: 20
Study 35896583 — intervention group
Group type: EXPERIMENTAL
Intervention: Confidential digital certificate of very low capacity for transmitting SARS‐CoV‐2 (intervention group)
Number of subjects: 1351
Study 35896583 — intervention group
Group type: COMPARATOR
Intervention: Non-attendees (control group)
Number of subjects: 1351
Study 35896583 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (intervention and control)
Number of subjects: 1351
Study 35896583 — intervention group
Group type: EXPERIMENTAL
Intervention: Survey respondents
Number of subjects: 1351
Study 34398236 — intervention group
Group type: EXPERIMENTAL
Intervention: Romidepsin (RMD) 5 mg/m2 in multidose cohort 4
Number of subjects: 59
Study 34398236 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 59
Study 34398236 — intervention group
Group type: EXPERIMENTAL
Intervention: Romidepsin (RMD)
Number of subjects: 59
Study 32459776 — intervention group
Group type: EXPERIMENTAL
Intervention: Collagenase clostridium histolyticum injections
Number of subjects: 70
Study 32459776 — intervention group
Group type: COMPARATOR
Intervention: Percutaneous needle fasciotomy
Number of subjects: 70
Study 32317748 — intervention group
Group type: EXPERIMENTAL
Intervention: 320 mg/day anthocyanin
Number of subjects: 176
Study 32317748 — intervention group
Group type: EXPERIMENTAL
Intervention: Anthocyanin supplementation (0-320 mg/day)
Number of subjects: 176
Study 32317748 — intervention group
Group type: EXPERIMENTAL
Intervention: Anthocyanin supplementation (80-320 mg/day)
Number of subjects: 176
Study 32317748 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 176
Study 32413002 — intervention group
Group type: EXPERIMENTAL
Intervention: Contrast-rebalanced binocular game treatment (1 hour a day, 5 days a week)
Number of subjects: 48
Study 32413002 — intervention group
Group type: COMPARATOR
Intervention: Patching treatment (2 hours a day, 7 days a week)
Number of subjects: 48
Study 35730261 — intervention group
Group type: EXPERIMENTAL
Intervention: Acrylic resin anterior bite plane (ABP)
Number of subjects: 66
Study 35730261 — intervention group
Group type: EXPERIMENTAL
Intervention: Thermoplastic bite plane (TBP)
Number of subjects: 66
Study 35730261 — intervention group
Group type: COMPARATOR
Intervention: Untreated control group
Number of subjects: 66
Study 33267812 — intervention group
Group type: EXPERIMENTAL
Intervention: Xerostomia
Number of subjects: 1076
Study 33267812 — intervention group
Group type: EXPERIMENTAL
Intervention: Dysphagia
Number of subjects: 1076
Study 33267812 — intervention group
Group type: EXPERIMENTAL
Intervention: Masticatory performance
Number of subjects: 1076
Study 33267812 — intervention group
Group type: EXPERIMENTAL
Intervention: Number of functional teeth
Number of subjects: 1076
Study 33267812 — intervention group
Group type: EXPERIMENTAL
Intervention: Occlusal condition
Number of subjects: 1076
Study 36129891 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraoperative VR in addition to monitored anesthesia care (MAC)
Number of subjects: 40
Study 36129891 — intervention group
Group type: COMPARATOR
Intervention: Usual MAC (control group)
Number of subjects: 40
Study 33564957 — intervention group
Group type: EXPERIMENTAL
Intervention: AGV + Bevacizumab
Number of subjects: 63
Study 33564957 — intervention group
Group type: COMPARATOR
Intervention: AGV alone
Number of subjects: 63
Study 33277819 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive statin therapy
Number of subjects: 4461
Study 33277819 — intervention group
Group type: COMPARATOR
Intervention: Standard statin therapy
Number of subjects: 4461
Study 33277819 — intervention group
Group type: EXPERIMENTAL
Intervention: 1-year eGFR decline
Number of subjects: 4461
Study 32444872 — intervention group
Group type: EXPERIMENTAL
Intervention: MIBT-APBI (multicatheter interstitial brachytherapy)
Number of subjects: 0
Study 32444872 — intervention group
Group type: COMPARATOR
Intervention: 3D-CRT-APBI (three-dimensional conformal external beam radiotherapy)
Number of subjects: 0
Study 32444872 — intervention group
Group type: COMPARATOR
Intervention: Alternative APBI techniques (intraoperative electrons, 50-kV x-rays)
Number of subjects: 0
Study 33054371 — intervention group
Group type: EXPERIMENTAL
Intervention: Avatars displaying participant's own face
Number of subjects: 305
Study 33054371 — intervention group
Group type: EXPERIMENTAL
Intervention: Avatars displaying participant's own face wearing sports clothes
Number of subjects: 305
Study 33054371 — intervention group
Group type: COMPARATOR
Intervention: Avatars displaying stranger's face wearing formal clothes
Number of subjects: 305
Study 32975024 — intervention group
Group type: EXPERIMENTAL
Intervention: Tamsulosin + Mirabegron
Number of subjects: 566
Study 32975024 — intervention group
Group type: COMPARATOR
Intervention: Tamsulosin + Placebo
Number of subjects: 566
Study 32832978 — intervention group
Group type: COMPARATOR
Intervention: Fremanezumab (quarterly or monthly dosing)
Number of subjects: 0
Study 35152754 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic Combined Intrarenal Surgery (ECIRS)
Number of subjects: 6
Study 35152754 — intervention group
Group type: COMPARATOR
Intervention: Percutaneous Nephrolithotomy (PCNL)
Number of subjects: 6
Study 33893671 — intervention group
Group type: EXPERIMENTAL
Intervention: Curcumin (500 mg)
Number of subjects: 84
Study 33893671 — intervention group
Group type: EXPERIMENTAL
Intervention: Zinc (30 mg)
Number of subjects: 84
Study 33893671 — intervention group
Group type: EXPERIMENTAL
Intervention: Zinc and Curcumin
Number of subjects: 84
Study 33893671 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 84
Study 32530124 — intervention group
Group type: EXPERIMENTAL
Intervention: Collagen drink
Number of subjects: 50
Study 32530124 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study 32597041 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Flow Nasal Cannula (HFNC)
Number of subjects: 60
Study 32597041 — intervention group
Group type: COMPARATOR
Intervention: Conventional Oxygen Therapy (COT)
Number of subjects: 60
Study 36599608 — intervention group
Group type: EXPERIMENTAL
Intervention: Aficamten
Number of subjects: 41
Study 36599608 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 41
Study 34591428 — intervention group
Group type: EXPERIMENTAL
Intervention: Regional radiation therapy 50‐55 Gy and intermediate dose of α2b‐interferon (RT + IFN)
Number of subjects: 96
Study 34591428 — intervention group
Group type: COMPARATOR
Intervention: Intermediate dose of α2b‐interferon alone (IFN)
Number of subjects: 96
Study 34591428 — intervention group
Group type: EXPERIMENTAL
Intervention: RT + IFN
Number of subjects: 96
Study 34591428 — intervention group
Group type: COMPARATOR
Intervention: IFN
Number of subjects: 96
Study 32866951 — intervention group
Group type: EXPERIMENTAL
Intervention: Prenatal surgery
Number of subjects: 183
Study 32866951 — intervention group
Group type: COMPARATOR
Intervention: Standard postnatal repair
Number of subjects: 183
Study 35832433 — intervention group
Group type: EXPERIMENTAL
Intervention: Laser-assisted zona thinning (LAT)
Number of subjects: 315
Study 34666794 — intervention group
Group type: EXPERIMENTAL
Intervention: Improved mosquito proof polyvinyl chloride (PVC) lids
Number of subjects: 332
Study 34666794 — intervention group
Group type: COMPARATOR
Intervention: Iron lids (control)
Number of subjects: 332
Study 34666794 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre-intervention survey
Number of subjects: 332
Study 34666794 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-intervention survey
Number of subjects: 332
Study 34666794 — intervention group
Group type: EXPERIMENTAL
Intervention: Community awareness assessment
Number of subjects: 332
Study 35416447 — intervention group
Group type: EXPERIMENTAL
Intervention: Exp2% (experimental SE + 2% biosilicate)
Number of subjects: 20
Study 35416447 — intervention group
Group type: EXPERIMENTAL
Intervention: Exp5% (experimental SE + 5% biosilicate)
Number of subjects: 20
Study 35416447 — intervention group
Group type: EXPERIMENTAL
Intervention: Exp2% and Exp5%
Number of subjects: 20
Study 35416447 — intervention group
Group type: COMPARATOR
Intervention: Exp0% (negative control)
Number of subjects: 20
Study 35416447 — intervention group
Group type: COMPARATOR
Intervention: AdheSE (positive control)
Number of subjects: 20
Study 35726226 — intervention group
Group type: EXPERIMENTAL
Intervention: Painless rehabilitation care
Number of subjects: 124
Study 33289072 — intervention group
Group type: EXPERIMENTAL
Intervention: Intact FGF23 levels
Number of subjects: 2376
Study 33289072 — intervention group
Group type: EXPERIMENTAL
Intervention: Intact FGF23 levels in the highest quartile
Number of subjects: 2376
Study 36087070 — intervention group
Group type: EXPERIMENTAL
Intervention: Darolutamide
Number of subjects: 1559
Study 36087070 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1559
Study 32796734 — intervention group
Group type: EXPERIMENTAL
Intervention: High-SDS diet
Number of subjects: 8
Study 32796734 — intervention group
Group type: COMPARATOR
Intervention: Low-SDS diet
Number of subjects: 8
Study 34936847 — intervention group
Group type: EXPERIMENTAL
Intervention: Cluster 1 (high time adherence, n=75)
Number of subjects: 98
Study 34936847 — intervention group
Group type: EXPERIMENTAL
Intervention: Cluster 2 (low time adherence, n=23)
Number of subjects: 98
Study 34936847 — intervention group
Group type: EXPERIMENTAL
Intervention: Both clusters
Number of subjects: 98
Study 35359881 — intervention group
Group type: EXPERIMENTAL
Intervention: Collaborative Nursing Intervention (CNI)
Number of subjects: 72
Study 35359881 — intervention group
Group type: COMPARATOR
Intervention: Routine Nursing (Control Group)
Number of subjects: 72
Study 33481052 — intervention group
Group type: EXPERIMENTAL
Intervention: SPP-24 levels measured in serum using ELISA; mean SPP-24 was 167.7 ± 101.1 ng/mL (range 33.4–633.6 ng/mL)
Number of subjects: 192
Study 33481052 — intervention group
Group type: EXPERIMENTAL
Intervention: SPP-24 levels measured in serum; adjusted for age, eGFR, and sex
Number of subjects: 192
Study 32057442 — intervention group
Group type: EXPERIMENTAL
Intervention: PEG + DTZ
Number of subjects: 48
Study 32057442 — intervention group
Group type: COMPARATOR
Intervention: PEG + Placebo
Number of subjects: 48
Study 34269493 — intervention group
Group type: EXPERIMENTAL
Intervention: Online Acceptance and Commitment Therapy (ACT)
Number of subjects: 49
Study 34269493 — intervention group
Group type: EXPERIMENTAL
Intervention: Online Compassion-Focused Therapy (CFT)
Number of subjects: 49
Study 34269493 — intervention group
Group type: COMPARATOR
Intervention: Control (not specified, but implied as inactive controls in previous studies)
Number of subjects: 49
Study 34350491 — intervention group
Group type: EXPERIMENTAL
Intervention: Mycophenolate mofetil (MMF) in addition to prednisolone
Number of subjects: 15
Study 34350491 — intervention group
Group type: EXPERIMENTAL
Intervention: Mycophenolate mofetil (MMF)
Number of subjects: 15
Study 34350491 — intervention group
Group type: COMPARATOR
Intervention: Prednisolone
Number of subjects: 15
Study 34728250 — intervention group
Group type: EXPERIMENTAL
Intervention: TAU augmented with the 5-min FoodT app daily for 4 weeks (n = 40)
Number of subjects: 80
Study 34728250 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU; n = 40)
Number of subjects: 80
Study 33594922 — intervention group
Group type: EXPERIMENTAL
Intervention: LNG-IUD
Number of subjects: 60
Study 33594922 — intervention group
Group type: COMPARATOR
Intervention: Copper-IUD
Number of subjects: 60
Study 33491367 — intervention group
Group type: EXPERIMENTAL
Intervention: Conical Standard (CS) implants
Number of subjects: 33
Study 33491367 — intervention group
Group type: COMPARATOR
Intervention: Internal Hex (IH) implants
Number of subjects: 33
Study 33491367 — intervention group
Group type: EXPERIMENTAL
Intervention: CS implants
Number of subjects: 33
Study 33491367 — intervention group
Group type: EXPERIMENTAL
Intervention: CS and IH implants
Number of subjects: 33
Study 34515098 — intervention group
Group type: EXPERIMENTAL
Intervention: Thulium laser (L)
Number of subjects: 12
Study 34515098 — intervention group
Group type: EXPERIMENTAL
Intervention: Photodynamic therapy (PDT)
Number of subjects: 12
Study 34515098 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined L-PDT
Number of subjects: 12
Study 34515098 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 12
Study 34126564 — intervention group
Group type: EXPERIMENTAL
Intervention: NIO-P
Number of subjects: 65
Study 34126564 — intervention group
Group type: EXPERIMENTAL
Intervention: EZ-IO
Number of subjects: 65
Study 34126564 — intervention group
Group type: EXPERIMENTAL
Intervention: Jamshidi needle
Number of subjects: 65
Study 34126564 — intervention group
Group type: COMPARATOR
Intervention: IV access
Number of subjects: 65
Study 32796401 — intervention group
Group type: EXPERIMENTAL
Intervention: S. boulardii CNCM I‐3799 (5 billion CFU twice daily for 5 days)
Number of subjects: 100
Study 32796401 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study 32796401 — intervention group
Group type: EXPERIMENTAL
Intervention: S. boulardii CNCM I‐3799
Number of subjects: 100
Study 36027758 — intervention group
Group type: EXPERIMENTAL
Intervention: Living Peace Intervention (LPint)
Number of subjects: 1736
Study 36027758 — intervention group
Group type: COMPARATOR
Intervention: Control (villages affected by conflict)
Number of subjects: 1736
Study 33690202 — intervention group
Group type: EXPERIMENTAL
Intervention: Addition of ascorbic acid (vitamin C) standards (spikes) into isolated samples
Number of subjects: 30
Study 33690202 — intervention group
Group type: COMPARATOR
Intervention: Control group (samples without vitamin C spikes)
Number of subjects: 30
Study 32956178 — intervention group
Group type: EXPERIMENTAL
Intervention: Azathioprine (AZA) monotherapy
Number of subjects: 55
Study 32956178 — intervention group
Group type: COMPARATOR
Intervention: Combination therapy (CT)
Number of subjects: 55
Study 34730813 — intervention group
Group type: EXPERIMENTAL
Intervention: Sources of Meaning Card Method (SoMeCaM) with standard care
Number of subjects: 42
Study 34730813 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 42
Study 34349376 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Number of subjects: 90
Study 34349376 — intervention group
Group type: COMPARATOR
Intervention: Fentanyl
Number of subjects: 90